Skip to main content
Premium Trial:

Request an Annual Quote

Set the Date

Daniel MacArthur gives us the lowdown from AGBT, the annual sequencing bonanza. While there's a lot of good data being presented, the overarching theme is the evolving battle between third-gen sequencing companies, he says at Genetic Future. Illumina said in a presentation early in the week that they'd be able to "routinely generate 95 Gb (that's 95 billion bases, the equivalent of 30 human genomes) of DNA sequence per run" by the end of the year. "Most people I spoke to seemed to feel that Illumina's claims were quite realistic -- and they'd better be, because competition is coming from relative newcomers to the field." Complete Genomics CEO Clifford Reid brought the drama, as well as some preliminary data, in his talk. "I think there was little doubt in the audience's mind that this is a serious new contender in the DNA sequencing field," MacArthur writes.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.